Sotrovimab For The Treatment Of Covid-19 Arrived In Large Quantities

A large batch of Sotrovimab drugs, which is used to treat mild to moderate cases of Covid-19, arrived in Kuwait, Al Anbaa reported.

Well-informed health sources told the daily that the drug will be distributed to hospitals specialized in treating corona within the next two weeks, after setting up the treatment protocol.

Sotrovimab is a monoclonal antibody drug and is used to treat mild to moderate cases of Covid-19 in adults and children (12 years and over and weighing at least 40 kilograms) at risk of Covid-19, such as people 65 years of age or older, or those who suffer from certain medical conditions, noting that this drug is not used for Covid-19 patients who are receiving hospital treatment or who need oxygen therapy due to their infection with the Covid-19 virus.

The clinical studies of Sotrovimab have shown effective results, as the drug reduced the cases of hospitalization or death by 85%,  it is a monoclonal antibody directed specifically against the barbed protein of SARS-CoV-2 and is designed to prevent the attachment and entry of the virus. to human cells.

 

SOURCE  :    TIMES KUWAIT

Comments Post Comment

Leave a Comment

Submit